31.3 C
Vientiane
Tuesday, August 5, 2025
spot_img

Cision PR Newswire

LA ROCHE-POSAY AND GLOBAL SKIN HEALTH EXPERTS UNITE TO WARN ABOUT LONG TERM CONSEQUENCES OF DANGEROUS ‘BURN LINES’ SOCIAL MEDIA TREND

PARIS, Aug. 5, 2025 /PRNewswire/ -- A viral TikTok challenge known as "Burn Lines" or "Sunburn Tattoos" is gaining alarming traction among teenagers and young adults worldwide. The trend, which involves placing tape or stencils on the skin to intentionally burn patterned tan lines, has sparked widespread concern among global...

Aon Appoints Jo Ann Jenkins to Board of Directors

DUBLIN, Aug. 5, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional...

High-Trend International Group Announces the Reverse Split Record Date

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- High-Trend International Group (the "Registrant" or the...

John Hinshaw Joins Digile as Strategic Advisor & Mentor to Accelerate AI-Led Growth and Global Expansion

SINGAPORE, Aug. 5, 2025 /PRNewswire/ -- Digile, a leading digital transformation and AI solutions...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...

WXT Surged 101% in 24 hours, And the Price Exceeded $0.339.Why Can WXT Go to the Moon?

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Platform tokens have gained increased attention in this bull market, with notable examples from leading exchanges. Amid this...

CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...

Nature’s Miracle Holding, Inc. Announces Up to $29.7 Million Financing

ONTARIO, Calif., Jan. 13, 2025 /PRNewswire/ -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services...